Telix Pharmaceuticals Ltd

TLX chart

Telix Pharmaceuticals Ltd news

• What does the proposed ITM merger mean for Telix Pharmaceuticals (ASX:TLX)?

  Kalkine · Nov 10, 1:20 AM EST

• Telix Pharmaceuticals Limited (TLX) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 8, 4:36 AM EST

• Telix Pharmaceuticals Limited (TLX) stock price, news, quote and history

  Yahoo Finance Australia · Nov 7, 10:44 PM EST

• 3 Australian Growth Stocks With Revenue Growth Up To 52%

  Yahoo Finance · Nov 7, 8:11 AM EST

• Telix Pharmaceuticals Limited (T3X.F) Seasonal Returns Chart - Yahoo Finance

  Yahoo! Finance Canada · Nov 6, 9:25 AM EST

• Telix Pharmaceuticals Limited (TLX1N.MX) Seasonal returns chart - Yahoo Finance

  Yahoo Finance Singapore · Nov 6, 4:52 AM EST

• Telix Pharmaceuticals (ASX:TLX) Shares Fall Today: What Are Investors Watching After Its Q3 Update?

  Kalkine · Nov 6, 2:09 AM EST

• Healthcare Stocks on ASX Today: Ansell, Telix Pharmaceuticals and Ebos Group Shares Move Across the Sector

  Kalkine · Nov 6, 2:09 AM EST

• What Does the Planned ITM Merger Mean for Telix Pharmaceuticals (ASX:TLX) After Its Third-Quarter Update?

  Kalkine · Nov 6, 12:54 AM EST

• Profound Medical Corp (PROF) (Q3 2026) Earnings Call Highlights: Revenue Surges 86% as Pipeline ...

  Yahoo Finance · Nov 6, 12:26 AM EST

• What Could the ITM Merger Mean for Telix Pharmaceuticals (ASX:TLX)?

  Kalkine Media · Nov 5, 11:02 PM EST

• Telix Pharmaceuticals (ASX:TLX) Could Be 43% Undervalued Following Thera4Care Trial Selection

  Simply Wall St · Nov 5, 3:18 PM EST

Telix Pharmaceuticals Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-29
• 6-K6-K2026-10-21
• 6-K6-K2026-09-30
• 6-K6-K2026-09-21
• 6-K6-K2026-09-14
• 6-K6-K2026-09-02
• 6-K6-K2026-09-01
• 6-K6-K2026-08-20
• 6-K6-K2026-07-21
• 6-K6-K2026-07-02
• 6-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS2026-05-21
• 6-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS2026-04-23

About Telix Pharmaceuticals Ltd

Ticker

TLX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

North Melbourne, Australia

Incorporated in

Australia

Fiscal year end

December 31

SEC CIK

2007191

Frequently asked questions